RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Clinical Trials

In Focus: Clinical Trials

Posted 01 June 2009

The demand to develop drugs, devices and treatment regimens faster and at lower cost has exerted enormous pressure on drug development, particularly over the past 10 years. Financial costs have driven this business in extraordinary and sometimes unforeseen ways. Global outsourcing is one area that has received significant attention. This issue examines globalization as it relates to cost containment of clinical trials. We also look at other cost themes: opportunity, patient (safety), regulatory and reimbursement.

 

© 2022 Regulatory Affairs Professionals Society.